Hybrid eventIn-person & virtual
March 18–20, 2027Singapore · Village Hotel Changi

Talk Details · Materials 2024

The merging of artificial Intelligence and biomaterials: The future of personalized health solutions

Keynote · Virtual · Day 3

Abstract

About this talk

Artificial intelligence (AI) has revolutionized many fields by identifying patterns and optimizing processes. Despite the use of AI across numerous industries, its use in biomaterials is relatively absent. Here, in this invited talk, a review of the promise for the use of AI in biomaterials will be presented with a focus on using AI to optimize tissue growth, inhibit infection, and limit inflammation based on biomaterial properties. Specifically, here, in vivo studies were used in which biomaterial properties (such as surface, mechanical, electrical, etc. properties) were systematically changed and correlated using AI to modulations in tissue growth, infection, and inflammation. In one application, AI was used to optimize biomaterial properties specifically for orthopedic applications in which an optimal set of properties was identified for promoting bone growth while inhibiting infection and inflammation. The AI optimized biomaterial was confirmed using well established in vivo assays. In this manner, this presentation represents one of the few in which AI was integrated into biomaterial design to create new and improved orthopedic materials.

Audience Take Away Notes:

  • What is Artificial Intelligence (AI)
  • How AI is being used in biomaterials to improve device performance
  • What is the future for the use of AI in biomaterials and healthcare 

Speaker

About the speaker

Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States

View full speaker profile →

Join the Materials 2027 delegation

Singapore · March 18–20, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us